Skip to main content
PMC home page
BMC Pulmonary Medicine logoLink to BMC Pulmonary Medicine
. 2023 Oct 17;23:392. doi: 10.1186/s12890-023-02687-y

Correction: Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study

Khalid Al Sulaiman 1,2,3,4,✉, Ohoud Aljuhani 5, Ghazwa B Korayem 6, Ali F Altebainawi 7,8, Reham Alharbi 8, Maha Assadoon 1, Ramesh Vishwakarma 9, Nadia H Ismail 10,11, Asma A Alshehri 12, Faisal E Al Mutairi 1, Mashael AlFaifi 13, Abdullah F Alharthi 14, Abeer A Alenazi 12, Mai Alalawi 15, Omar Al Zumai 2,16,17, Hussain Al Haji 3,16,17, Sarah T Al Dughaish 18, Abdulrahman S Alawaji 2, Haifa A Alhaidal 2,3, Ghassan Al Ghamdi 3,19,20
PMCID: PMC10583410  PMID: 37848847

Correction: BMC Pulmonary Medicine 23, 315 (2023)

https://doi.org/10.1186/s12890-023-02603-4

Following publication of the original article [1], the authors flagged the following errors:

1) Affiliations 7, 8, and 11 had been incorrectly detailed.

2) The name of author Ali F. Altebainawi had been miswritten as Ali Altebainawi.

3) Affiliation 8 had been missed from author Ali F. Altebainawi (they are affiliated with affiliations 7 and 8).

The affiliations information has since been corrected in the published article and the corrected affiliations information can be seen in this erratum. The authors thank you for reading and apologize for any inconvenience caused.

Reference

  • 1.Al Sulaiman K, et al. Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study. BMC Pulm Med. 2023;23:315. doi: 10.1186/s12890-023-02603-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Pulmonary Medicine are provided here courtesy of BMC

RESOURCES